Comments on: AstraZeneca shares drop after new cancer treatment approval https://ukinvestormagazine.co.uk/astrazeneca-shares-drop-after-new-cancer-treatment-approval/ UK Investor Magazine provides breaking financial news and investment ideas Wed, 29 May 2019 11:01:43 +0000 hourly 1 https://wordpress.org/?v=6.9.4 By: ValiRx loss on the back of cancer treatment development - UK Investor Magazine https://ukinvestormagazine.co.uk/astrazeneca-shares-drop-after-new-cancer-treatment-approval/#comment-10478 Wed, 29 May 2019 11:01:43 +0000 https://ukinvestormagazine.co.uk/?p=12532#comment-10478 […] and cancer therapy development group ValiRx Plc (LON:VAL) reported a loss for the full-year through December, which […]

]]> By: AstraZeneca treatment for rare disease granted orphan status - UK Investor Magazine https://ukinvestormagazine.co.uk/astrazeneca-shares-drop-after-new-cancer-treatment-approval/#comment-9462 Wed, 06 Feb 2019 11:36:04 +0000 https://ukinvestormagazine.co.uk/?p=12532#comment-9462 […] last news from the latter portion of 2018 that the pharma juggernaut had developed a series of new cancer treatments, though the company experienced mixed […]

]]> By: Advanced Oncotherapy shares soar after cancer treatment milestone - UK Investor Magazine https://ukinvestormagazine.co.uk/astrazeneca-shares-drop-after-new-cancer-treatment-approval/#comment-8592 Wed, 10 Oct 2018 13:14:46 +0000 https://ukinvestormagazine.co.uk/?p=12532#comment-8592 […] morning, after the company announced it had reached a milestone in the development of its LIGHT cancer treatment […]

]]>